CPIX - Cumberland Pharmaceuticals Non-GAAP EPS of $0.10 revenue of $11.41M November, 08 2022 04:51 PM Cumberland Pharmaceuticals Inc. Cumberland Pharmaceuticals press release ( NASDAQ: CPIX ): Q3 Non-GAAP EPS of $0.10. Revenue of $11.41M (+40.9% Y/Y). Shares +6% . For further details see: Cumberland Pharmaceuticals Non-GAAP EPS of $0.10, revenue of $11.41M